WuXi Biologics (Cayman) Inc.
WXIBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8,279,182 | $9,669,839 | $6,395,222 | $9,003,280 |
| Short-Term Investments | $2,430,609 | $1,573,598 | $2,319,101 | $2,123,204 |
| Receivables | $5,786,808 | $6,184,425 | $5,158,395 | $3,273,111 |
| Inventory | $1,521,669 | $1,765,751 | $2,280,911 | $1,687,375 |
| Other Curr. Assets | $5,554,923 | $2,004,636 | $2,316,239 | $3,442,771 |
| Total Curr. Assets | $23,573,191 | $21,198,249 | $18,469,868 | $19,529,741 |
| Property Plant & Equip (Net) | $28,435,374 | $29,939,471 | $25,915,998 | $19,755,796 |
| Goodwill | $1,529,914 | $1,529,914 | $1,529,914 | $1,529,914 |
| Intangibles | $442,369 | $511,834 | $548,778 | $600,654 |
| Long-Term Investments | -$30,784 | $2,934,286 | $390,110 | $79,618 |
| Tax Assets | $444,318 | $235,783 | $222,568 | $220,787 |
| Other NC Assets | $2,583,053 | $226,189 | $2,487,149 | $2,316,113 |
| Total NC Assets | $33,404,244 | $35,377,477 | $31,094,517 | $24,502,882 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $56,977,435 | $56,575,726 | $49,564,385 | $44,032,623 |
| Liabilities | – | – | – | – |
| Payables | $747,147 | $833,266 | $794,388 | $617,784 |
| Short-Term Debt | $2,619,006 | $731,308 | $1,470,488 | $2,225,456 |
| Tax Payable | $720,343 | $705,116 | $831,331 | $606,761 |
| Deferred Revenue | $0 | $430,477 | $0 | $0 |
| Other Curr. Liab. | $4,534,755 | $4,935,853 | $6,222,390 | $4,805,688 |
| Total Curr. Liab. | $8,621,251 | $7,636,020 | $9,318,597 | $8,255,689 |
| LT Debt | $2,320,843 | $3,830,051 | $2,951,173 | $2,069,831 |
| Deferred Rev, NC | $460,466 | $969,233 | $949,462 | $876,726 |
| Deferred Tax Liab, NC | $97,306 | $122,540 | $132,076 | $124,211 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2,878,615 | $4,921,824 | $4,032,711 | $3,070,768 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,303,649 | $2,413,985 | $1,638,668 | $1,532,879 |
| Total Liabilities | $11,499,866 | $12,557,844 | $13,351,308 | $11,326,457 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $1,492,076 | $0 | $0 |
| Common Stock | $226 | $235 | $233 | $235 |
| Retained Earnings | $16,355,938 | $13,485,787 | $11,578,134 | $7,157,848 |
| AOCI | $0 | $1,781,784 | $1,367,014 | $593,128 |
| Other Equity | $25,463,045 | $23,571,715 | $22,102,026 | $24,527,382 |
| Total Equity | $41,819,209 | $40,331,597 | $35,047,407 | $32,278,593 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $3,658,360 | $3,686,285 | $1,165,670 | $427,573 |
| Total Liab. & Tot. Equity | $56,977,435 | $56,575,726 | $49,564,385 | $44,032,623 |
| Net Debt | -$3,339,333 | -$5,108,480 | -$1,973,561 | -$4,707,993 |